Genix Pharmaceuticals Corporation reported earnings results for the third quarter and nine months ended July 31, 2023. For the third quarter, the company reported revenue was CAD 0.002682 million. Net loss was CAD 0.164098 million compared to CAD 0.252361 million a year ago.
For the nine months, revenue was CAD 0.012347 million. Net loss was CAD 0.625153 million compared to CAD 0.818374 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.